Hagen Triendl

Senior Director of ML Research
View LinkedIn profile

Articles by

Hagen Triendl

AI Drug Discovery
Co-Folding AI

Grounding ApherisAffinity predictions in binding structure

Affinity scores should depend on how a compound binds. ApherisAffinity uses structurally validated training data, a geometry-aware affinity head and disrupted-binding-site negatives, so its predictions respond to target changes and rank compounds in a real discovery series better than Boltz‑2 and Nesso‑1.

Read the article